Is BIOLIFE SOLUTIONS INC (BLFS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 3.2% / 30% | 10.9% / 30% | 1.0% / 30% | 4.35% / 5% | ✓ HALAL |
| DJIM | 3.2% / 33% | 10.9% / 33% | 1.0% / 33% | 4.35% / 5% | ✓ HALAL |
| MSCI | 7.6% / 33% | 26.2% / 33% | 2.3% / 33% | 4.35% / 5% | ✓ HALAL |
| S&P | 3.2% / 33% | 10.9% / 33% | 1.0% / 33% | 4.35% / 5% | ✓ HALAL |
| FTSE | 7.6% / 33% | 26.2% / 33% | 2.3% / 50% | 4.35% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 64.6% | |
| Operating Margin | -0.3% | |
| Net Margin | -4.8% | |
| Return on Equity (ROE) | -3.4% | |
| Return on Assets (ROA) | -0.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $20M |
| Free Cash Flow | $416,000 |
| Total Debt | $18M |
| Debt-to-Equity | 4.8 |
| Current Ratio | 5.9 |
| Total Assets | $406M |
Price & Trading
| Last Close | $19.65 |
| 50-Day MA | $21.75 |
| 200-Day MA | $23.94 |
| Avg Volume | 411K |
| Beta | 1.9 |
|
52-Week Range
$17.86
| |
About BIOLIFE SOLUTIONS INC (BLFS)
BioLife Solutions, Inc. develops, manufactures, and markets bioproduction products and services for the cell and gene therapy (CGT) industry in the United States, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor Freeze Media that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; bioproduction products, such as human platelet lysates for cell expansion and CellSeal closed system vials that are used in CGT; CryoCase cryo-compatible transparent rigid containers for closed-system fill and retrieval, and automated cell processing machines; and the ThawSTAR line include automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals. It markets and sells its products directly, as well as through third party distributors. The company was incorporated in 1987 and is headquartered in Bothell, Washington.
Purification Calculator
As a halal stock with 4.35% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is BIOLIFE SOLUTIONS INC (BLFS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), BIOLIFE SOLUTIONS INC is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is BIOLIFE SOLUTIONS INC's debt ratio?
BIOLIFE SOLUTIONS INC's debt ratio is 3.2% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 7.6%.
Does BIOLIFE SOLUTIONS INC require dividend purification?
Yes, BIOLIFE SOLUTIONS INC has an impermissible income ratio of 4.35%, which means 4.35% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are BIOLIFE SOLUTIONS INC's key financial metrics?
BIOLIFE SOLUTIONS INC has a market capitalization of $898M, and revenue of $96M. The company maintains a gross margin of 64.6% and a net margin of -4.8%. Return on equity stands at -3.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.